IMMUNOHISTOCHEMICAL CHARACTERIZATION OF THE PLASMINOGEN-ACTIVATOR SYSTEM IN PSORIATIC EPIDERMIS

被引:33
作者
GISSLER, HM
FRANK, R
KRAMER, MD
机构
[1] UNIV HEIDELBERG,INST IMMUNOL & SEROL,IMMUNPATHOL LAB,NEUENHEIMER FELD 305,W-6900 HEIDELBERG,GERMANY
[2] UNIV HEIDELBERG,HAUTKLIN,W-6900 HEIDELBERG,GERMANY
关键词
D O I
10.1111/j.1365-2133.1993.tb00254.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The relative topographical distribution of urokinase-type plasminogen activator (uPA), tissue-type PA (tPA), PA-inhibitor-1 (PAI-1), PA-inhibitor-2 (PAI-2), plasmin(ogen), alpha2-antiplasmin, and alpha2-macroglobulin was studied in lesional epidermis of psoriasis vulgaris, and in normal epidermis, by immunohistochemistry. In psoriatic epidermis, tPA predominated, although uPA was found in some biopsies. PAs were not detected in normal epidermis. PAI-1 was not detected in normal epidermis and was only present in a proportion of biopsies of psoriatic lesions. PAI-2 was found in normal and psoriatic epidermis. Plasmin(ogen) was confined to the basal cell layer of normal epidermis, whereas in lesional psoriatic skin it was scattered throughout the epidermis. Alpha2-antiplasmin and alpha2-macroglobulin were not found in the epidermis of normal skin. In psoriatic epiderMiS alpha2-antiplasmin was confined to the subcorneal layer, whereas staining for alpha2-macroglobulin was found only in a proportion of biopsies, in the upper epidermis. Our immunohistological findings indicate that colocalization of tPA and its substrate plasminogen may allow efficient generation of plasmin, and that the focal absence of plasmin inhibitors may then favour the persistence of plasmin activity.
引用
收藏
页码:612 / 618
页数:7
相关论文
共 39 条
[1]   MESSENGER-RNA FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS PRESENT IN LESIONAL EPIDERMIS FROM PATIENTS WITH PSORIASIS, PEMPHIGUS, OR BULLOUS PEMPHIGOID, BUT IS NOT DETECTED IN NORMAL EPIDERMIS [J].
BAIRD, J ;
LAZARUS, GS ;
BELIN, D ;
VASSALLI, JD ;
BUSSO, N ;
GUBLER, P ;
JENSEN, PJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (05) :548-552
[2]   PLASMINOGEN ACTIVATION BY T-PA ON THE SURFACE OF HUMAN-MELANOMA CELLS IN THE PRESENCE OF ALPHA-2-MACROGLOBULIN SECRETION [J].
BIZIK, J ;
LIZONOVA, A ;
STEPHENS, RW ;
GROFOVA, M ;
VAHERI, A .
CELL REGULATION, 1990, 1 (12) :895-905
[3]   PLASMINOGEN BINDING-SITES IN NORMAL HUMAN SKIN [J].
BURGE, SM ;
MARSHALL, JM ;
CEDERHOLMWILLIAMS, SA .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 (01) :35-41
[4]  
COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
[5]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[6]   UNINVOLVED SKIN FROM PSORIATIC PATIENTS DEVELOPS SIGNS OF INVOLVED PSORIATIC SKIN AFTER BEING GRAFTED ONTO NUDE-MICE [J].
FRAKI, JE ;
BRIGGAMAN, RA ;
LAZARUS, GS .
SCIENCE, 1982, 215 (4533) :685-687
[7]   CORRELATION OF EPIDERMAL PLASMINOGEN-ACTIVATOR ACTIVITY WITH DISEASE-ACTIVITY IN PSORIASIS [J].
FRAKI, JE ;
LAZARUS, GS ;
GILGOR, RS ;
MARCHASE, P ;
SINGER, KH .
BRITISH JOURNAL OF DERMATOLOGY, 1983, 108 (01) :39-44
[8]   ENHANCED ASSOCIATION OF PLASMINOGEN PLASMIN WITH LESIONAL EPIDERMIS OF BULLOUS PEMPHIGOID [J].
GISSLER, HM ;
SIMON, MM ;
KRAMER, MD .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (03) :272-277
[9]  
GRONDAHLHANSEN J, 1985, BRIT J DERMATOL, V113, P257
[10]   IMMUNOHISTOCHEMICAL LOCALIZATION OF UROKINASE-TYPE AND TISSUE-TYPE PLASMINOGEN ACTIVATORS IN PSORIATIC SKIN [J].
GRONDAHLHANSEN, J ;
RALFKIAER, E ;
NIELSEN, LS ;
KRISTENSEN, P ;
FRENTZ, G ;
DANO, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (01) :28-32